Skip to content

A prospective, rsplit-face, controlled trial for the efficiacy and safety of Nd:YAG 1064-nm picosecond fractional laser with different engery in the treatment of photoaging

A prospective, rsplit-face, controlled trial for the efficiacy and safety of Nd:YAG 1064-nm picosecond fractional laser with different engery in the treatment of photoaging

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038667
Enrollment
Unknown
Registered
2020-09-27
Start date
2020-09-27
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PHOTOAGING

Interventions

low-energy group:low-energy Nd: YAG1064-nm laser
high-energy group:high-energy Nd: YAG1064-nm laser

Sponsors

Hospital for Skin Diseases (Institute of Dermatology), Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 35 to 70 years male or female; 2. Patients with Fitzpatrick skin type III-V; 3. Patients with facial photoaging; 4. Patients who agree to take pictures of the treatment area during the research and use it for scientific, educational or other purposes; 5. Patients who have fully understood the study before signing the study and voluntarily signed informed consent, and can complete all follow-up patients in accordance with the expected treatment procedure

Exclusion criteria

Exclusion criteria: 1. Active skin lesions on the face or symptoms of systemic infection; 2. Skin lesions such as melasma, brown-blue mole, and Ota mole on the face; 3. Pregnant and lactating women; 4, Recent sun-burn history; 5. Patients with a previous history of photosensitivity, who have taken drugs known to increase light sensitivity in the past 6 months; 6. Patients taking isotretinoin orally during the 12 months before the initial treatment; 7. In the past 3 months, the face has received surgical treatment including: minimally invasive, filling, injection, plastic surgery or ultraviolet light treatment, strong pulsed light, laser, radio frequency treatment 8. Patients with previous history of squamous cell carcinoma or melanoma; 9. The investigator believes that the subject has poor compliance or other organic diseases and is not suitable to participate in this clinical study.

Design outcomes

Primary

MeasureTime frame
Global Photoaging Score;

Secondary

MeasureTime frame
melanin index;Global Aesthetic Improvement Scale;Pain Visual Analogue Scale;Patient's satisfaction rate;Transeipdermal water loss(TEWL);

Countries

China

Contacts

Public ContactLING TONG

Hospital for Skin Diseases (Institute of Dermatology), Chinese Academy of Medical Sciences

ddlin@hotmail.com+86 13951902258

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026